Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tareq Salous

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|March 26, 2023
Challenges in the management of relapsed germ cell tumorsTareq Salous, Nabil Adra
Current Opinion in Oncology|April 4, 2024
Current outstanding challenges in germ cell tumorsTareq Salous, Nabil Adra
Current Opinion in Oncology|March 6, 2026
Recent developments and outstanding challenges in germ cell tumorsAhmed Bilal Khalid, Tareq Salous
Journal of Hematopathology|February 15, 2024
Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expressionRohit Gulati, Asma Abu-Salah, Tareq Salous, et al.
Cancer Medicine|February 6, 2025
Prediction Model for Brain Metastasis in Patients With Metastatic Germ-Cell TumorsTareq Salous, Ryan Ashkar, Sandra K Althouse, et al.
Cancer|November 24, 2022
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029Tareq Salous, Nikhil A Shukla, Sandra K Althouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity ModelMax J Gordon, Andy Kaempf, Andrea Sitlinger, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|March 26, 2023
Challenges in the management of relapsed germ cell tumorsTareq Salous, Nabil Adra
Current Opinion in Oncology|April 4, 2024
Current outstanding challenges in germ cell tumorsTareq Salous, Nabil Adra
Current Opinion in Oncology|March 6, 2026
Recent developments and outstanding challenges in germ cell tumorsAhmed Bilal Khalid, Tareq Salous
Journal of Hematopathology|February 15, 2024
Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expressionRohit Gulati, Asma Abu-Salah, Tareq Salous, et al.
Cancer Medicine|February 6, 2025
Prediction Model for Brain Metastasis in Patients With Metastatic Germ-Cell TumorsTareq Salous, Ryan Ashkar, Sandra K Althouse, et al.
Cancer|November 24, 2022
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029Tareq Salous, Nikhil A Shukla, Sandra K Althouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity ModelMax J Gordon, Andy Kaempf, Andrea Sitlinger, et al.
Pageof 1